Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP709137.RAVRO1VaLCkP5LtiwOVH5EALYldeC-w-uVLC9nHXCxe0E130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP709137.RAVRO1VaLCkP5LtiwOVH5EALYldeC-w-uVLC9nHXCxe0E130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP709137.RAVRO1VaLCkP5LtiwOVH5EALYldeC-w-uVLC9nHXCxe0E130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP709137.RAVRO1VaLCkP5LtiwOVH5EALYldeC-w-uVLC9nHXCxe0E130_provenance.
- NP709137.RAVRO1VaLCkP5LtiwOVH5EALYldeC-w-uVLC9nHXCxe0E130_assertion description "[Lansoprazole (LPZ), amoxicillin (AMPC) and clarithromycin (CAM) are commonly used drugs (LAC regimen) for Helicobacter pylori (H. pylori) eradication, but the eradication rate with this regimen was reported to be 70% to 90%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP709137.RAVRO1VaLCkP5LtiwOVH5EALYldeC-w-uVLC9nHXCxe0E130_provenance.
- NP709137.RAVRO1VaLCkP5LtiwOVH5EALYldeC-w-uVLC9nHXCxe0E130_assertion evidence source_evidence_literature NP709137.RAVRO1VaLCkP5LtiwOVH5EALYldeC-w-uVLC9nHXCxe0E130_provenance.
- NP709137.RAVRO1VaLCkP5LtiwOVH5EALYldeC-w-uVLC9nHXCxe0E130_assertion SIO_000772 21614934 NP709137.RAVRO1VaLCkP5LtiwOVH5EALYldeC-w-uVLC9nHXCxe0E130_provenance.
- NP709137.RAVRO1VaLCkP5LtiwOVH5EALYldeC-w-uVLC9nHXCxe0E130_assertion wasDerivedFrom befree-20140225 NP709137.RAVRO1VaLCkP5LtiwOVH5EALYldeC-w-uVLC9nHXCxe0E130_provenance.
- NP709137.RAVRO1VaLCkP5LtiwOVH5EALYldeC-w-uVLC9nHXCxe0E130_assertion wasGeneratedBy ECO_0000203 NP709137.RAVRO1VaLCkP5LtiwOVH5EALYldeC-w-uVLC9nHXCxe0E130_provenance.
- befree-20140225 importedOn "2014-02-25" NP709137.RAVRO1VaLCkP5LtiwOVH5EALYldeC-w-uVLC9nHXCxe0E130_provenance.